Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

You are viewing the site in preview mode

Skip to main content
Fig. 1 | Virology Journal

Fig. 1

From: Altered LY6E and TRIM6 expression in PBMCs correlated with HBsAg clearance and response to Peg-IFN-α treatment in HBeAg-negative chronic hepatitis B patients

Fig. 1

LY6E and TRIM6 mRNA expressions in PBMCs of untreated CHB patients and healthy controls. LY6E (A) and TRIM6 (B) mRNA levels in PBMCs were analysed by qRT-PCR. The expression levels were calculated using the 2^-ΔΔct method (Livak method), with β-actin as the reference gene. P < 0.05 considered as significant

Back to article page